Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Alfredo Ardia"'
Autor:
Mario Del Donno, Marc Decramer, Maureen P.M.H. Rutten-van Mölken, Thierry Troosters, Riccardo Pellegrino, Alfredo Ardia, Wilfried De Backer, Dario Olivieri, P. N. Richard Dekhuijzen, Cees L. A. van Herwaarden, Ida Lankhorst, C P Onno van Schayck
Publikováno v:
The Lancet (London), 365, 9470, pp. 1552-60
The lancet : international edition
The Lancet (London), 365, 1552-60
The lancet : international edition
The Lancet (London), 365, 1552-60
Contains fulltext : 47552.pdf (Publisher’s version ) (Closed access) BACKGROUND: Increased oxidative stress is important in the pathogenesis of chronic obstructive pulmonary disease (COPD). We postulated that treatment with the antioxidant N-acetyl
Publikováno v:
Current Therapeutic Research. 64:327-337
Background: Dysmenorrhea produces painful abdominal cramps that can disrupt the personal lives and productivity of women. Objective: The aim of this study was to compare the analgesic efficacy, including onset and duration of pain relief, peak effect
Publikováno v:
The Journal of Clinical Pharmacology. 42:904-911
The analgesic efficacy of an arginine salt of ibuprofen was compared to one of the commercially available forms of conventional ibuprofen in a 500-patient clinical trial in postoperative dental pain. Patients were administered a single dose of ibupro
Autor:
Mitchell B. Max, Teresa Pallotta, Thomas Norwood, Peter McL. Black, Paul J. Desjardins, Alfredo Ardia
Publikováno v:
Clinical Therapeutics. 24:1072-1089
Because of its enhanced pharmacokinetic characteristics, ibuprofen arginate might be expected to provide faster pain relief than standard ibuprofen formulations in patients experiencing acute pain.This study assessed the analgesic efficacy, speed of
Autor:
Nicola Di Pietro, Roberto Latagliata, Luigi Resegotti, Maria Concetta Petti, Francesco Nobile, Franco Mandelli, Saverio Ladogana, Nicola Petti, Claudio Malleo, Emanuela Falconi, Bruno Rotoli, Giorgina Specchia, Fabrizio Ganzina, Enrico Geraci, Alfredo Ardia, Francesco Di Raimondo, Antonio Tabilio
Publikováno v:
European Journal of Cancer and Clinical Oncology. 27:750-755
255 patients with acute non-lymphoid leukaemia (ANLL), observed between October 1984 and June 1987, entered a chemotherapy regimen consisting of induction therapy with cytarabine in combination with idarubicin (IDA/ARA) or daunorubicin (DNR/ARA), fol
Autor:
Archil Shartava, Ardie Pack-Mabien, Alfredo Ardia, Steven R. Goodman, Mudhari Mulekar, Betty S. Pace
Publikováno v:
American journal of hematology. 73(1)
The extent to which dense and irreversible sickle cells (ISCs) contribute to vaso-occlusive episodes in sickle cell disease remains unclear. N-Acetylcysteine (NAC) inhibits dense cell and ISC formation in sickle erythrocytes in vitro and restores glu
Autor:
Tom Norwood, Paul J. Desjardins, Danny D. Shen, Lonnie H. Norris, Peter McL. Black, Maria B Papageorge, Alfredo Ardia
Publikováno v:
European journal of clinical pharmacology. 58(6)
Ibuprofen is a safe and effective analgesic, but some formulations have a slow onset of action. Ibuprofen arginate is a rapidly absorbed salt designed to promote more rapid onset of analgesia. A clinical trial was conducted in 226 patients with posto
Publikováno v:
Cardiovascular drugs and therapy. 9(2)
Plasma levels of lipoprotein-a [Lp(a)] > 30 mg/dl represent an independent risk factor for cardiovascular diseases with both proatherosclerotic and prothrombotic activity. The results of dietary or pharmacological treatment are not encouraging and ar
Autor:
R. Chiecca, S. Astolfi, Claudio Zanna, A. Piccolboni, M. M. Brunetti, M. Filippone, Francesco De Tomasi, Francesca Patarnello, C. Grassi, A. Allavena, Alfredo Ardia, Domenico Criscuolo
Publikováno v:
International Journal of Pharmaceutical Medicine. 14:177-178
Autor:
Cosimo Prantera, Mario Cottone, Giacomo Carlo Sturniolo, Francesco Pallone, Renzo Caprilli, Massimo Campieri, Anna Kohn, Vincenzo Savarino, Alfredo Ardia, Maurizio Vecchi, Salvatore Bellinvia
Publikováno v:
Gastroenterology. 136:A-65
Purpose: Basiliximab (BSX) is a chimeric monoclonal antibody that binds with high affinity to CD25, thereby inhibiting IL-2 binding, and IL-2 mediated proliferation of lymphocytes. Evidence suggests that IL-2 plays a role in the development of steroi